Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Grant/Award of 3,135 APRE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 3,135 | n/a |
| May 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Jul 2, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Jun 9, 2025 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,045 | n/a |
| Sep 30, 2024 | Molecular Templates, Inc. (MTEM) | Grant/Award | 1,000 | n/a |
| Jun 14, 2024 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 47,500 | n/a |
| Jun 15, 2023 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 35,000 | n/a |
| May 8, 2023 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 12,500 | n/a |
| Jun 3, 2022 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 9,146 | n/a |
| Jul 16, 2021 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 9,146 | n/a |